Tracheostomy Practices in Adult Intensive Care Units: A Multicenter Point-Prevalence Study in Izmir (IZ-TRACH)
IZ-TRACH
1 other identifier
observational
282
1 country
1
Brief Summary
This completed observational study describes physician-reported reasons for postponement among adults with an established tracheostomy who were present in participating intensive care units (ICUs) on a single survey day. The survey was conducted in eleven adult ICUs in six hospitals in Izmir, Turkey, on 8 September 2025. The census comprised 282 adults; 46 had a tracheostomy. All 46 contribute to the prevalence numerator. The main descriptive sample comprises 42 patients whose tracheostomy was established during the current admission; four patients with tracheostomies created before admission are excluded from patient-level clinical and outcome summaries. Previous clinical and procedural information was collected retrospectively, and postponement reasons were obtained from primary treating physicians. Mortality was assessed 30 days after the index day, on 8 October 2025. Analyses describe reason categories, total intubation-to-tracheostomy intervals, patient and procedural characteristics, recorded complications, and post-index in-hospital mortality. They cannot establish the duration attributable to family decision-making, preventability of postponement, or effects on outcomes. Registration and this clarification occurred after study completion; no prospective specification of the revised analyses is claimed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 8, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 8, 2025
CompletedFirst Submitted
Initial submission to the registry
February 5, 2026
CompletedFirst Posted
Study publicly available on registry
February 11, 2026
CompletedSeptember 22, 2026
September 1, 2026
1 month
February 5, 2026
September 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Recorded 30-day post-index in-hospital mortality
Proportion of the 42 current-admission tracheostomy patients with a recorded in-hospital death during the 30 days after the index-day census. Status was assessed by local investigators from records and the hospital information system on 8 October 2025. The time origin is 8 September 2025, not tracheostomy or ICU admission. Individual calendar death dates and discharge/transfer histories were unavailable in the available analysis dataset. The current 42-patient denominator was adopted during manuscript revision after study completion; exploratory reason-group summaries do not establish causal effects.
From the index date, 8 September 2025, to the follow-up assessment on 8 October 2025 (30 days)
Point-prevalence of tracheostomy and physician-reported reasons for postponement
Prevalence is the number with any established tracheostomy (46) divided by the full adult ICU census (282) on the index day. Reason distributions use the 42 current-admission tracheostomy patients. Primary treating physicians reported family-related reasons, hemodynamic instability, awaiting surgical eligibility or bleeding diathesis. Each patient had at most one reason reported; multiple reasons would have been recorded if reported. No reported reason does not demonstrate absence of postponement. These categories do not measure days attributable to family decisions or establish preventability. The 42-patient restriction and revised descriptive presentation were adopted after study completion.
Index-day census on 8 September 2025; preceding postponement reasons obtained retrospectively from treating physicians
Secondary Outcomes (5)
Total intubation-to-tracheostomy interval (days)
From endotracheal intubation to tracheostomy, retrospectively assessed through 8 September 2025
Distribution of tracheostomy techniques
Tracheostomies established before and present on the index day, 8 September 2025
Recorded early and late tracheostomy complications
From each patient's tracheostomy through the index day, 8 September 2025; observation duration varied between patients
APACHE II score and its discrimination for 30-day mortality
APACHE II assessed once at ICU admission; vital status assessed 30 days after the index date (8 September to 8 October 2025)
Causes of death among non-survivors
Up to 30 days after the index day
Study Arms (1)
Tracheostomy Patients
Adults aged 18 years or older with an established surgical or percutaneous tracheostomy who were present in a participating ICU on 8 September 2025. This group comprised 46 of the 282 adults in the census. The revised main descriptive analyses include 42 patients with tracheostomy established during the current admission; four with tracheostomy created before admission contribute only to prevalence and exclusion accounting. Tracheostomy was provided as clinical care and was not assigned by investigators.
Interventions
The application of surgical or percutaneous dilatational tracheostomy (Griggs guidewire dilating forceps or Ciaglia single-dilator techniques) for indications such as prolonged mechanical ventilation
Eligibility Criteria
Adults aged 18 years or older present in eleven participating adult ICUs across six hospitals in Izmir, Turkey, on 8 September 2025 formed the 282-person census. Forty-six had a surgical or percutaneous tracheostomy and contribute to overall prevalence. The main descriptive sample includes the 42 whose tracheostomy was established during the current admission. Four with tracheostomies created before admission are included only in census/prevalence counts and exclusion accounting. This revision of the analysis population does not change the census eligibility criteria or actual enrollment of 282.
You may qualify if:
- Aged 18 years and older
- Present in a participating adult ICU on the point-prevalence day
You may not qualify if:
- Patients younger than 18 years
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Izmir City Hospital
Izmir, Bayrakli, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Murat KAYKAC, M.D.
Izmir City Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 30 Days
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Anesthesiology and Reanimation Specialist, MD
Study Record Dates
First Submitted
February 5, 2026
First Posted
February 11, 2026
Study Start
September 8, 2025
Primary Completion
October 8, 2025
Study Completion
October 8, 2025
Last Updated
September 22, 2026
Record last verified: 2026-09